Literature DB >> 7364617

Angiotensin I conversion and vascular reactivity in pathophysiological states in dogs.

P J Leuenberger, S A Stalcup, L M Greenbaum, R B Mellins, G M Turino.   

Abstract

To determine if angiotension converting enzyme activity is altered by acute pathophysiological insults, we assessed angiotensin I conversion using a blood pressure response technique in anesthetized dogs studied during acute 100% O2 breathing and acute acid-base derangements. Also, we determined systemic vascular reactivity to angiotensin II by measuring the magnitude and duration of the arterial blood pressure response to intra-arterial injections of angiotensin II under these same conditions. Angiotensin I conversion found in normoxia [91 +/- 7 (SD)%] was unchanged by acute acidosis, alkalosis, and hyperoxia. During acute hyperoxia the mean half time of the hypertensive response increased from 68 +/- 25 (SD) s at a PaO2 of 112 +/- 18 (SD) Torr to 100 +/- 34 (SD) s at a PaO2 of 491 +/- 47 (SD) Torr (P less than 0.01). No other pathophysiological condition studied had any effect on reactivity of systemic vasculature to angiotensin II. We conclude that, except during acute hypoxia as previously shown, converting enzyme activity is resistant to other pathophysiological insults and that vascular responsiveness to angiotensin II is enhanced by hyperoxia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7364617     DOI: 10.1152/jappl.1980.48.2.308

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  3 in total

1.  Effects of angiotensin II on arterial pressure, renin and aldosterone during exercise.

Authors:  R Fagard; P Lijnen; A Amery
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

2.  Research in pediatric surgery.

Authors:  C J Stolar; R P Altman
Journal:  World J Surg       Date:  1985-04       Impact factor: 3.352

3.  Impaired angiotensin conversion and bradykinin clearance in experimental canine pulmonary emphysema.

Authors:  S A Stalcup; P J Leuenberger; J S Lipset; M M Osman; J M Cerreta; R B Mellins; G M Turino
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.